lobbying_activities: 1450398

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1450398	434d2e97-368f-494c-a67e-f371a0d2f7cd	Q3	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	401040928	AMERICAN ASSOCIATION OF NURSE PRACTITIONERS	2013	third_quarter	PHA	Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drugH.R. 1919 - Safeguarding America's Pharmaceuticals Act S. 621 Safe Prescribing Act S. 959 Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 Compounding Clarity Act H.R. 3204 Drug Quality and Security Act	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office		84089	0	0	2013-10-18T11:25:44.733000-04:00